A rapid heartbeat and shortness of breath could be signs of atrial fibrillation (AFib), an irregular heartbeat. Dr. Jim Stone, a cardiac electrophysiologist at North Medical Center in Tupelo, helps ...
Novartis has announced that it will be expanding its late-stage cardiovascular pipeline by acquiring Anthos Therapeutics for ...
Under the terms of the agreement, Novartis will pay $925 million upfront and up to $2.15 billion, contingent upon achievement ...
Compared with rivaroxaban, abelacimab is associated with fewer bleeding events in patients with AF and moderate to high risk for stroke.
Novartis has announced its acquisition of Anthos Therapeutics, a Boston-based biopharmaceutical company focused on developing abelacimab, an inve ...
Column written by Dr Kimberley Watkins] As we step into the second week of Heart Month, let’s show some love to your most ...
Looking ahead, the big question isn’t whether virtual medicine will stick around—it’s how it will evolve to meet our ...
Along with researchers in the Faculty of Health Sciences and the Faculty of Science, Western projects received a total of $17 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback